Press Releases | Microbix Biosystems Inc.
50646
page-template,page-template-blog-standard,page-template-blog-standard-php,page,page-id-50646,page-child,parent-pageid-1298,edgt-core-1.0,,vigor-ver-1.12, vertical_menu_with_scroll,side_menu_slide_with_content,width_370,wpb-js-composer js-comp-ver-5.2.1,vc_responsive

Press Releases

Microbix Announces First Shipment of Bioreactor Antigen

Customer Validation of New Manufacturing Process Completed TORONTO: September 13, 2017 – Microbix Biosystems Inc. (TSX: MBX), a developer and marketer of biological products and technologies, announces its first full-scale shipment of antigen produced using its new bioreactor manufacturing process, following customer validation. Microbix’ revenues are derived...

Read More

Microbix to Amend Share Purchase Warrant Terms

TORONTO August 24 2017 - Microbix Biosystems Inc. (TSX: MBX), a developer and marketer of biological products and technologies, announces it has applied to the TSX to amend the terms of 1,500,000 common share purchase warrants (the “Warrants”) issued in connection with a non-brokered private...

Read More

Microbix Announces Expanded Customer Supply Agreement – $25 Million of Expected Sales, With Approximately $10 Million of New Business

TORONTO, August 8, 2017 - Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, announces the execution of an agreement to supply an existing long-term customer with an increasing quantity of Microbix’ viral antigen products over the next five years, with the...

Read More